Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

“…This suggests that proper supplementation of vitamin D and vitamin E may enhance our resistance to SARS-CoV-2. Patients with primary basic diseases, especially those with chronic diseases such as hypertension, diabetes, coronary heart disease and tumor, are more susceptible to SARS-CoV-2 and their risk of poor prognosis will increase significantly after infection, because they have low systemic immunity as a result of the disease itself and treatments [71]. Therefore, it is particularly important to enhance self-resistance.…”

Managing COVID-19 in the oncology clinic and avoiding the distraction effect

“…It is well established that cancer patients are more susceptible to infections because of the immunosuppressive state caused by both anticancer treatments and surgery [1][2][3]. A recent study from Prof He and colleagues shows that the risk of developing severe events in COVID-19 disease is statistically significant higher in patients with cancer, with a hazard ratio of 3.56 [4]. A caution in interpreting the data is that the patient numbers are of course small, but the results are not unexpected.…”

COVID-19: Yet another coronavirus challenge in transplantation

“…(5) Those with cancer receiving chemotherapy as well as patients with multiple comorbidities are distinctively at a higher risk for severe illness. (5,6) However, information on the predilection, presentation and prognosis of COVID-19 in solid organ transplantation is sparse and has not been adequately reported.…”